Ra Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Ra Pharmaceuticals's estimated annual revenue is currently $2M per year.
- Ra Pharmaceuticals's estimated revenue per employee is $77,500
- Ra Pharmaceuticals's total funding is $226.9M.
Employee Data
- Ra Pharmaceuticals has 26 Employees.
- Ra Pharmaceuticals grew their employee count by 0% last year.
Ra Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Research Technician | Reveal Email/Phone |
Ra Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Ra Pharmaceuticals?
Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases.
keywords:N/A
$226.9M
Total Funding
26
Number of Employees
$2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ra Pharmaceuticals News
Initiate a Phase 2 trial for KIO-101 in the fourth quarter of 2022 to treat the Ocular Presentation of Rheumatoid Arthritis. Strengthen the...
It was a good year to be a pharmaceutical company, especially one that came up ... product first approved by the FDA in 2010 to treat rheumatoid arthritis,...
MyMD seeks to disrupt the $31 billion global market for rheumatoid arthritis (RA) drug therapies with MYMD-1, which could potentially prove...
Shares of Ra were up nearly 100 percent following the news, trading at $45.34 per share on the Nasdaq Thursday afternoon. Shares of UCB were up nearly 2 percent on the Brussels Stock Exchange. “Ra Pharma is an excellent strategic fit addressing multiple areas of UCB’s patient value growth strat ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.5M | 26 | -40% | N/A |
#2 | $10.4M | 26 | -47% | $124.9M |
#3 | $2.5M | 26 | -28% | N/A |
#4 | $6.5M | 26 | -54% | N/A |
#5 | $2M | 26 | 18% | $46.8M |